HomeTop StoriesBRS files complaint with ED against company linked to Telangana CM’s relative

BRS files complaint with ED against company linked to Telangana CM’s relative

Hyderabad, Nov 19 (IANS) Bharat Rashtra Samithi (BRS) leader Krishank Manne has lodged a complaint with the Enforcement Directorate against Maximen Pharma allegedly owned by Telangana Chief Minister A. Revanth Reddy’s son-in-law, Goluguri Satyanarayana.

Krishank, who is the social media convener of BRS, sought a probe into financial irregularities by the company and claimed that Satyanarayana’s family members have ED charges of bank fraud and diversion of funds.

According to the BRS leader, the ED in July named Goluguri Ramakrishna Reddy and others in a case of siphoning close to Rs 311 crore. The diverted funds were allegedly used to acquire immovable properties and were also invested in their other businesses. Ramakrishna Reddy is the uncle of Satyanarayana.

Krishank claimed that the Congress government is forcibly acquiring lands in the Chief Minister’s Assembly constituency Kodangal to benefit Maxbien Pharma.

Goluguri Ramakrishna is the brother of Goluguri Venkat and they are directors in numerous businesses. Goluguri Venkat is the brother-in-law of Revanth Reddy and father to Goluguri Satyanarayana.

The BRS leader alleged that the Chief Minister’s son-in-law’s family has multiple cases of bank defaults. As Maxbien Pharma boasts of crores of rupees in investments through shares, ED has to investigate its financials and source of funds. He also claimed that Revanth Reddy also opened a private hospital in Warangal in which Maxbien Pharma directors have shares.

BRS working president K. T. Rama Rao had also spoken about the role of Goluguri Satyanarayana as director in Maxbien Pharma with 16 lakh shares. He claimed that Annam Sharath and his firm SVS Facility jointly have 21 lakh shares, and a private hospital in which he is a shareholder was opened recently by Chief Minister Revanth Reddy in Warangal are pointing concerns.

“As ED mentioned the diversion of funds, there is a suspicion of the possibility of diverting crores of funds to Maxbien Pharma. There are several bank fraud cases, and bank default cases against Goluguri Family members. For example, Bank of Baroda and Syndicate Bank have auctioned assets as Goluguri family failed to pay crores of bank defaults,” Krishank said.

Krishank said all necessary evidence, including documents of shares and financials of Goluguri Satyanarayana, have been produced along with ED’s official statement in the ongoing investigation.

–IANS

ms/dpb

Go to Source

Disclaimer

The information contained in this website is for general information purposes only. The information is provided by TodayIndia.news and while we endeavour to keep the information up to date and correct, we make no representations or warranties of any kind, express or implied, about the completeness, accuracy, reliability, suitability or availability with respect to the website or the information, products, services, or related graphics contained on the website for any purpose. Any reliance you place on such information is therefore strictly at your own risk.

In no event will we be liable for any loss or damage including without limitation, indirect or consequential loss or damage, or any loss or damage whatsoever arising from loss of data or profits arising out of, or in connection with, the use of this website.

Through this website you are able to link to other websites which are not under the control of TodayIndia.news We have no control over the nature, content and availability of those sites. The inclusion of any links does not necessarily imply a recommendation or endorse the views expressed within them.

Every effort is made to keep the website up and running smoothly. However, TodayIndia.news takes no responsibility for, and will not be liable for, the website being temporarily unavailable due to technical issues beyond our control.

For any legal details or query please visit original source link given with news or click on Go to Source.

Our translation service aims to offer the most accurate translation possible and we rarely experience any issues with news post. However, as the translation is carried out by third part tool there is a possibility for error to cause the occasional inaccuracy. We therefore require you to accept this disclaimer before confirming any translation news with us.

If you are not willing to accept this disclaimer then we recommend reading news post in its original language.

RELATED ARTICLES
- Advertisment -

Most Popular